The credit watch negative is a result of Essentia Health’s upcoming $800 million capital project, which S&P expects will pressure the rating.
“While we recognize that the capital project may benefit Essentia’s enterprise profile in the long term, we believe that flexibility at the current rating is limited given the size of the project and the likely significant capital spending and/or debt,” said S&P credit analyst Aamna Shah.
More articles on healthcare finance:
TransUnion Healthcare keeping contract with VA
Central Learning launches 3rd coding contest
S&P ratings on ProMedica debt unchanged after HCR ManorCare acquisition
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
